A 14-year-old White adolescent boy presented to our pediatric primary care office
for an initial well-child examination and sports physical examination. He stated that
the high school coach was recruiting him to play basketball because he was tall and
had long arms and large hands, which allowed him to “easily recover rebounds.” On
the preparticipation physical examination form (
American Academy of Family Physicians, American Academy of Pediatrics, American College
of Sports Medicine, American Medical Society for Sports Medicine, American Orthopaedic
Society for Sports Medicine, and American Osteopathic Academy of Sports Medicine,
2010
), he denied syncopal episodes, chest pain or pressure with exercise, palpitations,
or shortness of breath, and he did not have a past medical history of heart problems
or seizures. He did, however, have a positive family history of two relatives dying
suddenly from “heart problems” in their 40s. His family did not know any details of
their family's heart problems and was unaware of any genetic diseases in the family.American Academy of Family Physicians, American Academy of Pediatrics, American College
of Sports Medicine, American Medical Society for Sports Medicine, American Orthopaedic
Society for Sports Medicine, and American Osteopathic Academy of Sports Medicine
Preparticipation physical exam form.
Preparticipation physical exam form.
American Academy of Pediatrics,
Grove Village, IL2010
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Pediatric Health CareAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Preparticipation physical exam form.American Academy of Pediatrics, Grove Village, IL2010 (Retrieved from)
- International nosology of heritable disorders of connective tissue, Berlin, 1986.American Journal of Medical Genetics. 1988; 29: 581-594
- Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task force 7: Aortic diseases, including Marfan syndrome: A scientific statement from the American Heart Association and American College of Cardiology.Journal of the American College of Cardiology. 2015; 66: 12398-12405
- Losartan added to β-blockade therapy for aortic root dilation in MFS: a randomized, open-label pilot study.Mayo Clinic Proceedings. 2013; 88: 271-276
- Update of the UND-FBN1 mutation database and creation of an FBN1 polymorphism database.Human Mutation. 2003; 22: 199-208
- Revised diagnostic criteria for the MFS.American Journal of Medical Genetics. 1996; 62: 417-426
- MFS caused by a recurrent de novo missense mutation in the fibrillin gene.Nature. 1991; 352: 337-339
- The effect of losartan on progressive aortic dilatation in patients with Marfan's syndrome: A meta-analysis of prospective randomized clinical trials.International Journal of Cardiology. 2016; 217: 190-194
- Losartan reduces aortic dilatation rate in adults with MFS: A randomized controlled trial.European Heart Journal. 2013; 34: 3491-3500
- Losartan, an AT1 antagonist, prevents aortic aneurysms in a mouse model of MFS.Science. 2006; 312: 117-121
- 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine.Circulation. 2010; 121: e266-e369
- Evidence for a critical contribution of haploinsufficiency in complex pathogenesis of MFS.Journal of Clinical Investigation. 2004; 114: 172-181
- Marfan's syndrome.Lancet. 2005; 366: 1965-1974
- Aortic root dilatation among young competitive athletes: echocardiographic screening of 1929 athletes between 15 and 34 years of age.American Heart Journal. 2000; 139: 723-728
- Clinical signs of MFS in children under 10 years of age.Archives de Pédiatrie. 2013; 20: 1193-1200
- Pediatric Heart Network Investigators. Atenolol versus losartan in children and young adults with Marfan's syndrome.New England Journal of Medicine. 2014; 371: 2061-2071
- The revised Ghent nosology for the MFS.Journal of Medical Genetics. 2010; 47: 476-485
- Aneurysm syndromes caused by mutations in the TGF-β receptor.New England Journal of Medicine. 2006; 355: 788-798
- Un cas de deformation congenitale des quarte membres plus prononcee aux extremities caracterisee apr l'allongement de os acec un cerrtain degre d'amincissement.Bulletins et Mémoires de la Société Médicale des Hôpitaux de Paris. 1896; 13: 220-226
- Diagnostic accuracy of aortic root cross-sectional area/height ratio in children and young adults with Marfan and Loeys-Dietz syndrome.Congenital Heart Disease. 2016; 11: 276-282
- Circulating transforming growth factor-beta in MFS.Circulation. 2009; 120: 526-532
- What is Marfan syndrome? Fast Facts: An easy-to-read series of publications for the public.Author, Bethesda, MD2016 (Retrieved from)
- Marfan Syndrome and related disorders.in: Rimoin D.L. Connor J.M. Pyeritz R.E. Korf B.R. Emery and Rimoin's principles and practice of medical genetics. 6th ed. Churchill Livingstone, London2013
- Mutation screening of the fibrillin-1 (FBN1) gene in 76 unrelated patients with MFS or Marfanoid features leads to the identification of 11 novel and three previously reported mutations.Human Mutation. 2002; 20: 406-407
- FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders.Gene. 2016; 591: 279-291
- Life expectancy in the Marfan syndrome.The American Journal of Cardiology. 1995; 75: 157-160
- Recent clinical drug trials evidence in Marfan syndrome and clinical implications.Canadian Journal of Cardiology. 2016; 32: 66-77
- Effects of aortic root motion on wall stress in the Marfan aorta before and after personalised aortic root support (PEARS) surgery.Journal of Biomechanics. 2016; 49: 2076-2084
- Personalised external aortic root support (PEARS) in MFS: Analysis of 1-9 year outcomes by intention-to-treat in a cohort of the first 30 consecutive patients to receive a novel tissue and valve-conserving procedure, compared with the published results of aortic root replacement.Heart. 2014; 100: 969-975
- Natural history of cardiovascular manifestations in Marfan syndrome.Archives of Disease in Childhood. 2001; 84: 129-137
Biography
Heide S. Temples, Assistant Professor, College of Behavior, Social and Health Sciences, School of Nursing, Clemson University, Clemson, SC.
Biography
Curtis R. Rogers, Senior Clinical Geneticist, Greenwood Genetic Center, Greenville, SC.
Biography
Deborah Willoughby, Professor, College of Behavior, Social and Health Sciences, School of Nursing, Clemson University, Clemson, SC.
Biography
Bonnie Holaday, Professor, College of Behavior, Social and Health Sciences, School of Nursing, Clemson University, Clemson, SC.
Article info
Publication history
Published online: June 29, 2017
Footnotes
Conflicts of interest: None to report.
Identification
Copyright
© 2017 by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.
